The primary objective: To describe clinical features, treatment options and overall outcomes (progression free survival & overall survival) of Australasian patients with methotrexate associated DLBCL.

Update 19 February 2026 – manuscript in its first round of review and will then send it to the authors. Aiming for an abstract at EHA.

Update 1 June 2026 – EHA abstract accepted